Logo image of CTKB

CYTEK BIOSCIENCES INC (CTKB) Stock Analyst Ratings

NASDAQ:CTKB - Nasdaq - US23285D1090 - Common Stock - Currency: USD

5.12  -0.08 (-1.54%)

After market: 5.12 0 (0%)

Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to CTKB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 59.38% above the current price.
CTKB was analyzed by 12 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about CTKB.
In the previous month the buy percentage consensus was at a similar level.
CTKB was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

CTKB Historical Analyst RatingsCTKB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.125.308.678.169.45 - 3.56% 69.34% 59.38% 84.57%

Related screens

CTKB Current Analyst RatingCTKB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2024-11-11 Piper Sandler Maintains Overweight -> Overweight
2024-08-13 Piper Sandler Maintains Overweight -> Overweight
2024-05-13 Piper Sandler Maintains Overweight -> Overweight
2024-03-06 Piper Sandler Maintains Overweight -> Overweight
2024-02-29 Goldman Sachs Maintains Buy -> Buy
2023-12-14 Stephens & Co. Initiate Overweight
2023-11-09 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-10-24 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-10-16 Piper Sandler Maintains Overweight -> Overweight
2023-07-19 Raymond James Initiate Market Perform
2023-05-11 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-05-10 Goldman Sachs Maintains Buy
2023-03-07 Piper Sandler Maintains Overweight
2023-03-02 Goldman Sachs Maintains Buy
2023-03-02 Morgan Stanley Maintains Equal-Weight
2022-08-18 Piper Sandler Maintains Overweight
2022-08-12 Morgan Stanley Maintains Equal-Weight
2022-08-11 Goldman Sachs Maintains Buy
2022-07-14 Goldman Sachs Maintains Buy
2022-05-16 Piper Sandler Maintains Overweight
2022-05-13 Morgan Stanley Maintains Equal-Weight
2022-05-12 Goldman Sachs Maintains Buy
2022-04-13 Goldman Sachs Maintains Buy
2022-02-15 Morgan Stanley Maintains Equal-Weight
2021-08-17 Cowen & Co. Initiate Outperform
2021-08-17 Goldman Sachs Initiate Buy
2021-08-17 Morgan Stanley Initiate Equal-Weight
2021-08-17 Piper Sandler Initiate Overweight